1. The Lancet Global Health
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study 
Dimitrios Gouglas, MSc, Tung Thanh Le, MSc, Klara Henderson, PhD, Prof Aristidis Kaloudis, PhD, Trygve Danielsen, MSc, Nicholas Caspersen Hammersland, MSc, James M Robinson, MS, Penny M Heaton, MD, Prof John-Arne Røttingen, MD 
The Lancet Global Health 
DOI: /S X(18)
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND 4.0 license Terms and Conditions

2. Figure
Estimated cost of progressing at least one epidemic infectious disease vaccine from preclinical through to end of phase 2a
PoS=probabilities of success. Figures in US$.
The Lancet Global Health DOI: ( /S X(18) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND 4.0 license Terms and Conditions